Atlas Trials

Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity

Clinical trial NCT07574723 · RECRUITING

Trial details

NCT number
NCT07574723
Sponsor
Dasman Diabetes Institute
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Obesity
Start date
2026-05-15
Primary completion
2029-05-15
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.